找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Checkpoint Responses in Cancer Therapy; Wei Dai Book 2008 Humana Press 2008 DNA.apoptosis.biotechnology.cancer.cancer research.cancer ther

[復(fù)制鏈接]
樓主: Constrict
11#
發(fā)表于 2025-3-23 11:53:01 | 只看該作者
12#
發(fā)表于 2025-3-23 14:58:02 | 只看該作者
13#
發(fā)表于 2025-3-23 22:02:37 | 只看該作者
14#
發(fā)表于 2025-3-23 22:46:11 | 只看該作者
Cancer Drug Discovery and Developmenthttp://image.papertrans.cn/c/image/224213.jpg
15#
發(fā)表于 2025-3-24 05:28:32 | 只看該作者
https://doi.org/10.1007/978-1-4302-1834-0 end, RB function is commonly abrogated in tumorigenesis, thereby contributing to the uncontrolled proliferation of cancer cells. However, it is becoming increasingly clear that RB is not only involved in the etiology and progression of cancer, but also modifies the response to specific therapeutic
16#
發(fā)表于 2025-3-24 08:11:38 | 只看該作者
https://doi.org/10.1007/978-1-4302-1834-0structure of DNA in the cell, regulate under- and overwinding of the double helix, and remove knots and tangles from the genetic material. In order to perform their critical cellular functions, topoisomerases generate DNA strand breaks as requisite intermediates in their catalytic cycles. Consequent
17#
發(fā)表于 2025-3-24 12:26:53 | 只看該作者
https://doi.org/10.1007/978-1-4302-1834-0sm of the G2 checkpoint s cascade. In addition, screening procedures to identify candidate compounds, currently available compounds, and compounds in clinical trials with G2 checkpoint-abrogating potential are discussed.
18#
發(fā)表于 2025-3-24 14:58:12 | 只看該作者
19#
發(fā)表于 2025-3-24 19:27:08 | 只看該作者
20#
發(fā)表于 2025-3-25 01:30:48 | 只看該作者
Advanced and Alternate MapReduce Techniques,indle checkpoint is a cell-cycle surveillance mechanism that prevents premature sister-chromatid separation and ensures the fidelity of chromosome segregation. A defective spindle checkpoint results in aneuploidy and contributes to tumorigenesis. On the other hand, many tumor cells still exhibit a p
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 13:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
浑源县| 蓬莱市| 宝应县| 漠河县| 吉水县| 静宁县| 庄浪县| 犍为县| 平罗县| 光山县| 通山县| 绥滨县| 米脂县| 南充市| 和龙市| 连山| 白朗县| 太仆寺旗| 和静县| 瑞昌市| 油尖旺区| 西峡县| 芮城县| 高州市| 林口县| 临澧县| 镇宁| 辽中县| 三门峡市| 佛教| 大丰市| 团风县| 临西县| 盖州市| 北海市| 安多县| 乳山市| 建水县| 长治县| 红桥区| 正定县|